105 related articles for article (PubMed ID: 25691721)
21. Influenza virus resistance to neuraminidase inhibitors.
Samson M; Pizzorno A; Abed Y; Boivin G
Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
[TBL] [Abstract][Full Text] [Related]
22. The recognition event between virus and host cell receptor: a target for antiviral agents.
Lentz TL
J Gen Virol; 1990 Apr; 71 ( Pt 4)():751-66. PubMed ID: 2109039
[No Abstract] [Full Text] [Related]
23. Trial watch: Protease inhibitors show promise against HCV.
Nat Rev Drug Discov; 2009 Jan; 8(1):11. PubMed ID: 19116621
[No Abstract] [Full Text] [Related]
24. Antiviral Activity of Ergoferon against Group A Rotavirus.
Emelianova AG; Shilovskii IP; Sundukova MS; Khaitov MR; Epshtein OI
Bull Exp Biol Med; 2016 Oct; 161(6):806-807. PubMed ID: 27783292
[TBL] [Abstract][Full Text] [Related]
25. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors.
Boloor A; Hanway D; Joshi M; Winn DT; Mendez G; Walls M; Wei P; Qian F; Zhang X; Zhang Y; Hepperle ME; Li X; Campbell DA; Betancort JM
Bioorg Med Chem Lett; 2009 Oct; 19(19):5708-11. PubMed ID: 19713109
[TBL] [Abstract][Full Text] [Related]
27. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
28. Drug repurposing of minocycline against dengue virus infection.
Leela SL; Srisawat C; Sreekanth GP; Noisakran S; Yenchitsomanus PT; Limjindaporn T
Biochem Biophys Res Commun; 2016 Sep; 478(1):410-416. PubMed ID: 27396621
[TBL] [Abstract][Full Text] [Related]
29. Viral proteinases--possible targets of antiviral drugs.
Maliar T; Baláz S; Tandlich R; Sturdík E
Acta Virol; 2002; 46(3):131-40. PubMed ID: 12580374
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor.
Xiong H; Foulk M; Aschenbrenner L; Fan J; Tiong-Yip CL; Johnson KD; Moustakas D; Fleming PR; Brown DG; Zhang M; Ferguson D; Wu D; Yu Q
Bioorg Med Chem Lett; 2013 Dec; 23(24):6789-93. PubMed ID: 24211022
[TBL] [Abstract][Full Text] [Related]
31. Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
Sato M; Ito M; Suzuki S; Sakuma H; Takeyama A; Oda S; Watanabe M; Hashimoto K; Miyazaki K; Kawasaki Y; Hosoya M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1643-9. PubMed ID: 25547357
[TBL] [Abstract][Full Text] [Related]
32. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
[TBL] [Abstract][Full Text] [Related]
33. Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.
Wang CY; Huang AC; Hour MJ; Huang SH; Kung SH; Chen CH; Chen IC; Chang YS; Lien JC; Lin CW
Viruses; 2015 Jun; 7(6):3155-71. PubMed ID: 26090728
[TBL] [Abstract][Full Text] [Related]
34. [ANTIVIRAL ACTIVITY OF THE DIHYDROQUERCETIN DURING THE COXSACKIEVIRUS B4 REPLICATION IN VITRO].
Galochkina AV; Zarubaev VV; Kiselev OI; Babkin VA; Ostroukhova LA
Vopr Virusol; 2016; 61(1):27-31. PubMed ID: 27145597
[TBL] [Abstract][Full Text] [Related]
35. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
[TBL] [Abstract][Full Text] [Related]
36. Ipilimumab-induced hepatitis C viral suppression.
Minter S; Willner I; Shirai K
J Clin Oncol; 2013 Jul; 31(19):e307-8. PubMed ID: 23690418
[No Abstract] [Full Text] [Related]
37. [New strategy for targeting influenza virus replication].
Dias A; Bouvier D; Cusack S; Ruigrok RW; Crépin T
Med Sci (Paris); 2009 Apr; 25(4):352-4. PubMed ID: 19409186
[No Abstract] [Full Text] [Related]
38. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activity of cyclopentenone prostanoids.
Santoro MG
Trends Microbiol; 1997 Jul; 5(7):276-81. PubMed ID: 9234510
[TBL] [Abstract][Full Text] [Related]
40. [Antiviral action of antibiotics].
Shneĭder MA; Chizhov NP
Vopr Virusol; 1986; 31(1):18-31. PubMed ID: 2421485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
